(Q45012366)

English

Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Naohide Sato

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Koichiro Akakura

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Shigeo Isaka

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Hiroomi Nakatsu

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Masashi Tanaka

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Haruo Ito

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Motoyuki Masai

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Chiba Prostate Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

64

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

341-345

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

A controlled trial of leuprolide with and without flutamide in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). EORTC GU Group and EORTC Data Center

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Intermittent endocrine therapy for advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Intermittent androgen suppression with leuprolide and flutamide for prostate cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Intermittent androgen deprivation: update of cycling characteristics in patients without clinically apparent metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Intermittent androgen suppression in the treatment of metastatic prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Endocrine treatment of prostate cancer - recent developments and the future. Part 1: maximal androgen blockade, early vs delayed endocrine treatment and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Intermittent androgen suppression in prostate cancer: the Canadian experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2004.03.032

7 January 2021

Identifiers

10.1016/J.UROLOGY.2004.03.032

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

release_3qp6hu5nwrbh5d6bhqqrnaioey

1 reference

https://api.fatcat.wiki/v0/release/3qp6hu5nwrbh5d6bhqqrnaioey

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45012366&oldid=2062320957"